Atossa Therapeutics, Inc. (NASDAQ:ATOS) Q2 2023 Earnings Call Transcript August 14, 2023
Atossa Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.08 EPS, expectations were $-0.06.
Operator: Good morning, ladies and gentlemen, thank you for standing by and welcome to the Atossa Therapeutics Q2 2023 Conference Call. Please be advised today’s conference is being recorded. I would now like to hand the conference over to your first speaker today, Eric Van Zanten, Vice...
